Search - tctmd.com

Displaying 301 - 320 of 639

Sort: Relevancy | Date

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

January 31, 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

January 28, 2019

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

January 17, 2019

CAD Yes, Symptoms No: More Evidence Needed to Guide Care

News Daily News

CAD Yes, Symptoms No: More Evidence Needed to Guide Care

January 16, 2019

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

January 09, 2019

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

January 07, 2019

Many PCI Patients Treated in China Have No Angina Symptoms

News Daily News

Many PCI Patients Treated in China Have No Angina Symptoms

December 20, 2018

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

December 18, 2018

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

November 09, 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

News Conference News VIVA 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

November 06, 2018

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

News Daily News

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

November 05, 2018

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

News Daily News

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

October 31, 2018

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

October 16, 2018

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

News Conference News PCR London Valves 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

September 12, 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

September 11, 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

September 07, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.